CBS 2019
CBSMD教育中心
首页
CBS 2019
关于CBS
会议通知
会议组织
主办单位
南京市心血管病医院
亚洲分叉病变俱乐部
南京医科大学附属南京医院
南京市第一医院医学发展医疗救助基金会
协办单位
中华医学会心血管病学分会
国家卫生健康委能力建设和继续教育心血管病学专家委员会（CBCEC）
美国心血管造影和介入学会
亚洲心脏学会
北京合众关爱心脏健康基金会
联系我们
境内代表注册管理:
彭红娟 ：
+86-13913895477
徐海梅 ：+86-13914736846
cbsnj@cbsmd.cn
境外代表注册管理:
林玲 ： +86 (25) 52271398
+86-13951884596
cbs@cbsmd.cn
病例征集管理:
赵莹莹 ：+86-13815408517
sub@cbsmd.cn
地址：
江苏省南京市秦淮区长乐路68号，南京市心血管病医院9号楼905区心内科办公室
210006
主席团
主席团
大会主席
联合主席
教育中心
教育中心
• 线上教育 （ 注册后可使用个人定义界面搜集科研图书馆文献、下载教育资源、参与在线病例讨论。）
• 教育资源
• 科研动态
科研图书馆
科研图书馆
科研文章
> 急性冠脉综合征
> 动脉粥样硬化性心血管疾病
> 分叉支架
> 心脏肿瘤科
> 充血性心力衰竭
> 双重抗血小板治疗持续时间
> 药物涂层球囊
> 血流储备分数
> 血管内超声指导
> 光学相关断层扫描
> 肺动脉高压
> 旋磨术
> 血流动力学与动脉粥样硬化
> 左主干支架
> 经导管主动脉瓣置换
> 经皮左心耳封堵
> 二尖瓣/三尖瓣瓣膜
> 推荐文献
荐读文献
Management of Acute Myocardial Infarction During the COVID-19 Pandemic
CSC Expert Consensus on Principles of Clinical Management of Patients with Severe Emergent Cardiovascular Diseases during the COVID-19 Epidemic
ACC临床简报:新型冠状病毒对心脏的影响(2019-nCoV)
SCAI Expert Consensus Statement Update on Best Practices for Transradial Angiography and Intervention
Angiotensin–neprilysin inhibition versus enalapril in heart failure
Clinical Trial | By McMurray JJ, Packer M, PARADIGM-HF Investigators and Committees.
Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure
Clinical Trial | By McMurray JJ, Krum H, ATMOSPHERE Committees Investigators.
Cardiac Troponin Elevation in Patients Without a Specific Diagnosis
Original Research | By KM Eggers, T Jernberg, B Lindahl.
BACKGROUND - Cardiac troponin (cTn) elevation is a common finding in acutely admitted patients, even in the absence of acute coronary syndrome. In some of these patients, no etiology of cTn elevation can be identified. The term troponinemia is sometimes used to describe this scenario. OBJECTIVES - This study aimed to investigate the associations of cTn levels with clinical findings and long-term outcome in ...
Contemporary techniques in percutaneous coronary intervention for bifurcation lesions
Review Article | By Collet C, Mizukami T, Grundeken MJ.
Treatment of coronary bifurcation lesions with contemporary state-of-the-art percutaneous coronary intervention (PCI) is still associated with higher rate of adverse cardiovascular events compared to non-bifurcation lesions. Bench testing and virtual computer modeling have increased our understanding of bifurcation PCI guiding refinement in bifurcation techniques. New insights on bifurcation PCI have the potential to further improve clinical outcomes in...
Clinical Trial | By Wang TY, Kaltenbach LA, Cannon CP et al.
IMPORTANCE - Despite guideline recommendations, many patients discontinue P2Y12 inhibitor therapy earlier than the recommended 1 year after myocardial infarction (MI), and higher-potency P2Y12 inhibitors are underutilized. Cost is frequently cited as an explanation for both of these observations. OBJECTIVE - To determine whether removing co-payment barriers increases P2Y12 inhibitor persistence and lo...
Clinical Trial | By Moalem K, Baber U, Mehran R et al.
BACKGROUND - The disruption of dual antiplatelet therapy (DAPT) due to non-compliance or bleeding is known to significantly increase the risk of adverse outcomes after percutaneous coronary intervention (PCI). However, it is currently unknown if there are differences in the predictors and clinical impact of disruption due to non-compliance compared with bleeding. METHODS - The patterns of non-adherence t...
Switching P2Y12-receptor inhibitors in patients with coronary artery disease
Review Article | By Rollini F, Franchi F, Angiolillo DJ.
Dual antiplatelet therapy--the combination of aspirin and a P2Y12-receptor inhibitor--is the cornerstone of treatment of patients with acute coronary syndromes (ACS) and of those undergoing percutaneous coronary intervention. Prasugrel and ticagrelor have more prompt, potent, and predictable antiplatelet effects than those of clopidogrel, and result in reduced ischaemic outcomes in patients with ACS, albeit at the expense of an ...
Clinical Trial | By Valgimigli M, Frigoli E, MATRIX Investigators.
BACKGROUND - The Minimizing Adverse Haemorrhagic Events by Transradial Access Site and Systemic Implementation of Angiox (MATRIX) programme was designed to assess the comparative safety and effectiveness of radial versus femoral access and of bivalirudin versus unfractionated heparin with optional glycoprotein IIb/IIIa inhibitors in patients with the whole spectrum of acute coronary syndrome undergoing invasive manage...
English
CBS 2019
CBS 2019 主席团
教育中心
科研动态
